Stockscreener 앱 받기
9.62
0.63%
0.06
Erasca Inc 주식(ERAS)의 최신 뉴스
Erasca (ERAS) touches 3-year high as 4 analysts go bullish; gets 267% PT hike - MSN
Erasca Offers $7.50 Put Option, Attracting Investor Interest - Intellectia AI
Erasca (ERAS) Touches 3-Year High as 4 Analysts Go Bullish; Gets 267% PT Hike - Finviz
Erasca price target raised to $11 from $5 at Piper Sandler - TipRanks
Erasca Stock Surges 42% in a Week: Here's What You Should Know - Yahoo Finance
Functional Force: Precision Platforms Disrupt the 2026 Tumor Landscape - PR Newswire
HC Wainwright Has Strong Estimate for Erasca FY2027 Earnings - Defense World
Winners Losers: What is AXIS Capital Holdings Limiteds debt to equity ratioAnalyst Downgrade & Fast Gain Stock Tips - baoquankhu1.vn
Assessing Erasca (ERAS) Valuation After Encouraging Early ERAS-0015 Data At JP Morgan Conference - Yahoo Finance
Erasca Rallies Amid Acquisition Talks and Positive Price Target Revisions - StocksToTrade
Clear Street Elevates Erasca: Price Target Stands Tall at $11 - timothysykes.com
FY2027 Earnings Forecast for Erasca Issued By HC Wainwright - MarketBeat
Erasca (ERAS) Is Up 60.7% After Early ERAS-0015 Data Highlights Pan-RAS Franchise Ambitions - Yahoo Finance
Erasca (ERAS) Hits Fresh High Anew as Firm Gets up to 267% PT Hike - Insider Monkey
Erasca stock hits 52-week high at 8.33 USD By Investing.com - Investing.com Nigeria
Erasca (NASDAQ:ERAS) Trading Up 7.7% Following Analyst Upgrade - Defense World
Erasca (ERAS) Price Target Increased by 30.91% to 6.53 - Nasdaq
Erasca stock jumps 10% as Wall Street lifts targets to $11 on ERAS-0015 data - TechStock²
Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff - Benzinga
Erasca (NASDAQ:ERAS) Trading Up 7.7% After Analyst Upgrade - MarketBeat
RAS buzz lifts Erasca | ApexOncoClinical Trials news and analysis - Oncology Pipeline
Erasca (ERAS) Climbs to 3-Year High as Analyst Hikes PT by 83% - Finviz
Analysts Offer Insights on Healthcare Companies: Regeneron (REGN), Erasca (ERAS) and Connect Biopharma Holdings (CNTB) - The Globe and Mail
Erasca Insider Sells $671K as Stock Jumps 189% This Past Year - AOL.com
ERAS: Lead RAS-targeting programs show promising early efficacy and safety, with key data expected in 2024 - TradingView — Track All Markets
Erasca stock price target raised to $11 from $6 at H.C. Wainwright - Investing.com Nigeria
ERAS Stock Update: HC Wainwright & Co. Raises Price Target to $1 - GuruFocus
HC Wainwright Issues Positive Forecast for Erasca (NASDAQ:ERAS) Stock Price - MarketBeat
Erasca (NASDAQ:ERAS) Hits New 52-Week High – Time to Buy? - Defense World
Erasca price target raised to $11 from $3 at Clear Street - TipRanks
Erasca (NASDAQ:ERAS) Shares Down 6.7%Here's Why - MarketBeat
Stifel raises Erasca stock price target to $10 on pipeline updates - Investing.com Canada
Erasca reports early responses with RAS-targeting cancer drug By Investing.com - Investing.com Nigeria
Erasca reports early responses with RAS-targeting cancer drug - Investing.com
Erasca Highlights Accelerated Progress in RAS-Targeted Trials - TipRanks
Erasca, Inc. Announces Clinical Progress and Milestones for RAS-Targeting Franchise - TradingView — Track All Markets
Erasca Stocks Surge Amid Merck Negotiations and AbbVie Interest - timothysykes.com
Erasca (NASDAQ:ERAS) Shares Gap Up – Should You Buy? - Defense World
Erasca (ERAS) Faces FDA Trial Pause and New Patent Win Is Its RAS Strategy Balanced? - simplywall.st
Erasca Stock Surges as Market Eyes Revolution Medicines Acquisition - StocksToTrade
Analyst Confidence High in Erasca (ERAS) Amid Pipeline Advancement and Earlier Q3 2025 Results - MSN
Why Erasca Inc. stock could be next big winner2025 Price Momentum & Daily Stock Trend Watchlist - Улправда
Ebun Garner Sells 120,000 Shares of Erasca (NASDAQ:ERAS) Stock - Defense World
Erasca (NASDAQ:ERAS) Earns Overweight Rating from Analysts at Piper Sandler - Defense World
Erasca price target raised to $6 from $4 at Stifel - MSN
Erasca Stock Surges Amid Merger Talks and Positive Analyst Ratings - StocksToTrade
Erasca Inc. (ERAS) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Erasca (NASDAQ:ERAS) Shares Gap UpShould You Buy? - MarketBeat
Erasca (NASDAQ:ERAS) Stock Rating Upgraded by Piper Sandler - MarketBeat
Why Erasca Inc. stock appeals to analystsEarnings Growth Report & Weekly High Potential Stock Alerts - Улправда
Risk Analysis: Why Erasca Inc stock is favored by pension fundsNew Guidance & Proven Capital Preservation Tips - Bộ Nội Vụ
4.73%
0.92%
자본화:
|
볼륨(24시간):